Cargando…
An In Vitro Comparison of Costimulatory Domains in Chimeric Antigen Receptor T Cell for Breast Cancer Treatment
Adoptive cellular therapy with chimeric antigen receptor (CAR) T cells has emerged as a potential novel treatment for various cancers. In this study, we have generated CAR T cells targeting mucin-1 (MUC1), which is an aberrantly glycosylated antigen overexpressed on breast cancer cells. Two differen...
Autores principales: | Khuisangeam, Nattarika, Jewmoung, Sirirut, Thaiwong, Rattapoom, Tudsamran, Suparat, Hirankarn, Nattiya, Suppipat, Koramit, Tawinwung, Supannikar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708373/ https://www.ncbi.nlm.nih.gov/pubmed/36457849 http://dx.doi.org/10.1155/2022/2449373 |
Ejemplares similares
-
MicroRNA‐mediated metabolic reprogramming of chimeric antigen receptor T cells
por: Rad, Seyed Mohammad Ali Hosseini, et al.
Publicado: (2022) -
Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness
por: Pe, Kristine Cate S., et al.
Publicado: (2022) -
Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations
por: Weinkove, Robert, et al.
Publicado: (2019) -
Metabolic and Mitochondrial Functioning in Chimeric Antigen Receptor (CAR)—T Cells
por: Rad S. M., Ali Hosseini, et al.
Publicado: (2021) -
Sulforaphane Induces Cell Cycle Arrest and Apoptosis in Acute Lymphoblastic Leukemia Cells
por: Suppipat, Koramit, et al.
Publicado: (2012)